1. Efficacy of galcanezumab in patients with episodic cluster headaches and a history of preventive treatment failure. (27th May 2021) Authors: Plato, Brian; Andrews, J Scott; Rettiganti, Mallikarjuna; Tockhorn-Heidenreich, Antje; Bardos, Jennifer; Wenzel, Richard; Kuruppu, Dulanji; Ambrosini, Anna Journal: Cephalalgia reports Issue: Volume 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment. Issue 1 (22nd November 2021) Authors: Láinez, Miguel J. A.; Schoenen, Jean; Stroud, Chad; Bardos, Jennifer; Bangs, Mark; Kemmer, Phebe; Wenzel, Richard; Kuruppu, Dulanji K.; Martinez, James Michael; Oakes, Tina M. Journal: Headache Issue: Volume 62:Issue 1(2022) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster Headache. Issue 10 (11th November 2020) Authors: Kudrow, David; Andrews, J. Scott; Rettiganti, Mallikarjuna; Oakes, Tina; Bardos, Jennifer; Gaul, Charly; Riesenberg, Robert; Wenzel, Richard; Kuruppu, Dulanji; Martinez, James Journal: Headache Issue: Volume 60:Issue 10(2020) Page Start: 2254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗